Gerresheimer AG showed strong revenue growth in the second quarter of 2021.
“The new company focus on sustainable growth, innovation and providing solutions for our customers is bearing fruits. We revealed our strengths in the second quarter. Prefillable syringes and other high-value solutions such as for biotech drugs are the main drivers. The delivery of injection vials is running as planned. We expect a strong second half of the year and confirm our guidance for 2021,” says Dietmar Siemssen, CEO of Gerresheimer AG.
In the second quarter of 2021, Gerresheimer AG generated organic Group revenues of EUR 377m. Revenues increased organically by 7.5 %, with revenues in the core business growing by 7.1 % year on year. The Plastics & Devices Division recorded organic growth of 4.4 % in the second quarter of 2021. The company achieved considerable growth in revenues in pharmaceutical primary packaging solutions made of plastic and in the syringes business in particular. Organic revenues in the Primary Packaging Glass Division rose by 10.3 % year on year. Significant revenue increases were recorded for high-value solutions in particular, such as Elite Glass products.
Adjusted EBITDA in the core business stood at EUR 85 million, corresponding to an organic growth of 3.1 %. The organic adjusted EBITDA margin in the core business amounted to 22.8 %. Adjusted net income stood at EUR 41 million. Adjusted earnings per share stood at EUR 1.28, which is a year-on-year increase of 19.1 %.
Forecast
Outlook for the financial year 2021 (core business, currency adjusted):
Medium term (core business, net of currency effects):
The Quarterly Statement for the second quarter of 2021 is available here:
https://www.gerresheimer.com/en/company/investor-relations/reports
15.07.2021, Gerresheimer AG
此网站新闻材料的版权属于公司或第三方的新闻提供者，其所有权利保留。所有新闻材料对其访问者只能限于其本人使用，并且使用此材料的风险由其使用者独自自行承担。严禁对新闻材料进行再次发布和其它商业利用. 作为商业贸易的用途。如果新闻材料由第三方提供，当应用此新闻材料时，每个使用者都同意遵守，并且受此特定的项目的约束。Glass Global并不代表及认可新闻材料中所包含的内容及新闻中的外部网站的内容的准确性及可靠性。
Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.